Mwanzo207940 • KRX
add
Samsung Biologics Co Ltd
Bei iliyotangulia
₩ 1,000,000.00
Bei za siku
₩ 1,005,000.00 - ₩ 1,044,000.00
Bei za mwaka
₩ 721,000.00 - ₩ 1,113,000.00
Thamani ya kampuni katika soko
72.03T KRW
Wastani wa hisa zilizouzwa
elfu 71.47
Uwiano wa bei na mapato
68.43
Mgao wa faida
-
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (KRW) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.19T | 14.81% |
Matumizi ya uendeshaji wa biashara | 202.29B | 11.50% |
Mapato halisi | 264.47B | 10.03% |
Kiwango cha faida halisi | 22.28 | -4.17% |
Mapato kwa kila hisa | elfu 3.72 | 10.07% |
EBITDA | 495.40B | 8.39% |
Asilimia ya kodi ya mapato | 9.12% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (KRW) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 988.11B | -45.63% |
Jumla ya mali | 16.03T | 0.87% |
Jumla ya dhima | 5.43T | -14.30% |
Jumla ya hisa | 10.59T | — |
hisa zilizosalia | 71.17M | — |
Uwiano wa bei na thamani | 6.72 | — |
Faida inayotokana na mali | 5.23% | — |
Faida inayotokana mtaji | 7.18% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (KRW) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 264.47B | 10.03% |
Pesa kutokana na shughuli | 740.39B | 154.07% |
Pesa kutokana na uwekezaji | -437.12B | -17.41% |
Pesa kutokana na ufadhili | -713.37B | -297.72% |
Mabadiliko halisi ya pesa taslimu | -433.28B | -69.49% |
Mtiririko huru wa pesa | -12.12B | -237.42% |
Kuhusu
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2011
Tovuti
Wafanyakazi
4,744
